Matinas BioPharma Holdings Inc MTNB

Morningstar Rating
$0.80 −0.01 (1.26%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MTNB is trading at a LOCK|!&!L? premium.
Price
$0.81
Fair Value
LOCK|&vB>t!
Uncertainty
LOCK|!L<MC
1-Star Price
LOCK|l>>Qy?^
5-Star Price
LOCK|c!MCLNG
Economic Moat
LOCK|Rwv
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.81
Day Range
$0.75–0.80
52-Week Range
$0.75–14.63
Bid/Ask
$0.70 / $0.80
Shares Outstanding
1.11M
Market Cap
$890,711.05
Volume/Avg
37,089 / 91,909

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
2

Valuation

Metric
MTNB
Price/Earnings (Normalized)
—
Price/Book Value
0.19
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
MTNB
Quick Ratio
1.62
Current Ratio
1.78
Interest Coverage
—
Quick Ratio
MTNB

Profitability

Metric
MTNB
Return on Assets (Normalized)
−107.09%
Return on Equity (Normalized)
−171.93%
Return on Invested Capital (Normalized)
−136.81%
Return on Assets
MTNB

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|&tbTB&>LOCK|qh%!$132B
Regeneron Pharmaceuticals Inc
REGN
LOCK|##W!zbLOCK|bVj&$96B
Moderna Inc
MRNA
LOCK|xM@%X<&LOCK|B%V$81B
argenx SE ADR
ARGX
LOCK|<@c$rZYLOCK|T?z$59B
BeOne Medicines Ltd ADR
ONC
LOCK|&Cq&R?LOCK|Cpj$47B
Royalty Pharma PLC Class A
RPRX
LOCK|BG&RbB$LOCK|&qCSR$30B
Incyte Corp
INCY
LOCK|r>?K#>LOCK|L%$24B
BioNTech SE ADR
BNTX
LOCK|hqzwRJLOCK|M>b$20B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|>z^S@%LOCK|lK!cT$20B
BridgeBio Pharma Inc
BBIO
LOCK|ZZS<?cLOCK|c&$15B

Sponsor Center